18 January 2017Americas

FTC and DoJ update antitrust guidelines

The Federal Trade Commission (FTC) and the Department of Justice (DoJ) have issued an update to the Antitrust Guidelines for Licensing of Intellectual Property, modernising the 1995 guidelines.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

FTC launches pharma merger analysis group

18 March 2021 The Federal Trade Commission (FTC) is launching a new international working group in an “imperative” move to better analyse the impact of pharmaceutical mergers.

Generics

Teva charged in DoJ antitrust probe into generic drug price-fixing

26 August 2020 Teva Pharmaceuticals has been charged with conspiring to fix prices, rig bids, and allocate customers for generic drugs, the US Department of Justice has announced.

Americas

DOJ chief wades into dental antitrust case in rare intervention

9 July 2020 The antitrust chief of the US Justice Department (DOJ) made a rare appearance in court when he requested that the US Court of Appeals for the Eleventh Circuit reject a defence used by a medical and dental board against an antitrust lawsuit.

More features

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

FTC and DoJ update antitrust guidelines

More on this story

Editor's picks

Editor's picks

More features